Online citations, reference lists, and bibliographies.
← Back to Search

Lipid-polymer Hybrid Nanoparticles: Synthesis Strategies And Biomedical Applications.

V. Dave, Kajal Tak, Amit Sohgaura, A. Gupta, Veera Sadhu, K. R. Reddy
Published 2019 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This review article is an updated overview on lipid-polymer hybrid nanoparticles (LPHNs) including the various types of LPHNs polymers used in their preparation, various methods of preparation, their physiochemical, in-vitro and in-vivo evaluation parameters and their application in various delivery systems. LPHNs show a combined advantage of biodegradable polymeric nanoparticles and liposomes. LPHNs mainly consist of a biodegradable polymeric material core containing drugs or any substances which are to be encapsulated then this core is further enclosed by a phospholipid layer i.e. lipid PEG layer. LPHNs show good physical strength and biocompatibility. The hybrid structural design can offer various benefits such as controlled particle size, high drug loading, surface functionality with various ligands (antibody fragments, peptides, monoclonal antibodies, aptamers, and folate molecules), and encapsulation of combinational therapeutic agents, showing prolonged release of drug and drug circulates in the blood for longer duration. Significantly, the LPHNs have recently been confirmed as a better drug delivery route and good cellular delivery efficacy of various drugs as compared to polymeric nanoparticles and liposomes.
This paper references
10.1016/J.EJPB.2006.10.022
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
H. L. Wong (2007)
10.1021/mp900316a
Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells.
C. Hu (2010)
10.1016/j.biomaterials.2010.07.082
PLGA/polymeric liposome for targeted drug and gene co-delivery.
H. Wang (2010)
10.1016/j.jconrel.2008.02.014
Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.
Y. Li (2008)
10.1016/j.ijpharm.2009.08.033
Production of hybrid lipid-based particles loaded with inorganic nanoparticles and active compounds for prolonged topical release.
C. García-González (2009)
10.2147/IJN.S25646
The comparison of protein-entrapped liposomes and lipoparticles: preparation, characterization, and efficacy of cellular uptake
W. Chang (2011)
10.1021/mp100390w
In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.
Xingfang Su (2011)
10.1016/J.CES.2007.08.006
Chemotherapeutic engineering : Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168h in vivo
S. Feng (2007)
10.1038/nrg1577
Towards safe, non-viral therapeutic gene expression in humans
D. Glover (2005)
10.1208/s12248-009-9143-y
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
M. Aldosari (2009)
10.1021/nl2035354
Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.
Warefta Hasan (2012)
10.1039/B804933E
Polymer-supported lipid shells, onions, and flowers.
A. Bershteyn (2008)
10.1002/JPS.20591
Development of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles.
C. Hitzman (2006)
10.1016/j.bioactmat.2017.07.002
Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system
V. Dave (2017)
10.1142/S179398441000016X
LIPID–POLYMER HYBRID NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS
Li I. Zhang (2010)
10.1021/JA070748I
Polymer-caged lipsomes: a pH-responsive delivery system with high stability.
S. Lee (2007)
10.1016/j.ijpharm.2011.12.045
A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Y. Wang (2012)
10.1021/nn800275r
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
L. Zhang (2008)
10.1016/J.PARTIC.2011.08.007
Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles
Wean Sin Cheow (2012)
10.1021/BM700753Q
Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids.
Julie Thévenot (2007)
10.1016/j.jconrel.2010.07.113
Nanoparticles by spray drying using innovative new technology: the Büchi nano spray dryer B-90.
X. Li (2010)
10.1002/smll.201000631
Combinatorial drug conjugation enables nanoparticle dual-drug delivery.
S. Aryal (2010)
10.1016/j.addr.2011.12.009
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Laura M Ensign (2012)
10.1371/journal.pone.0031472
Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
J. Moon (2012)
10.1039/c2cc32149a
Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging.
A. Mieszawska (2012)
10.5138/IJDD.2010.0975.0215.02007
Drug delivery to eye: Special reference to nanoparticles
Swarnali Das (2010)
10.1016/j.ijpharm.2010.02.008
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells.
Y. Zheng (2010)
10.1016/J.JCONREL.2003.09.013
An overview of current delivery systems in cancer gene therapy.
Anas El-Aneed (2004)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/j.drudis.2014.09.020
Recent advances in controlled pulmonary drug delivery.
Zhenglin Liang (2015)
10.1016/0169-409X(95)00017-2
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
10.1016/j.ijpharm.2012.03.042
Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
Guo Chen-yu (2012)
10.4028/www.scientific.net/AST.57.148
A New Drug Vehicle - Lipid Coated Biodegradable Nanoparticles
J. Schäfer (2008)
10.1016/j.ejpb.2012.03.004
Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Peiqi Zhao (2012)
10.1016/J.JCONREL.2007.05.021
Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
Dana J Gary (2007)
10.1016/j.ijpharm.2012.07.042
A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
M. Narvekar (2012)
10.1016/j.actbio.2012.11.006
Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release.
S. D. Kong (2013)
10.1088/0957-4484/22/18/185601
Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chih-Hang Chu (2011)
10.1007/978-1-60761-609-2_17
Targeting of nanoparticles: folate receptor.
Sumith A. Kularatne (2010)
10.1007/s11095-004-9003-5
Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery
M. Lee (2004)
10.1038/nature03794
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Shiladitya Sengupta (2005)
10.1016/S0169-409X(02)00118-7
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
R. Mueller (2002)
10.1016/j.nano.2012.11.010
Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform.
B. Mandal (2013)
10.1038/SJ.MT.6300101
Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA.
J. Heyes (2007)
10.1073/pnas.1106634108
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
C. Hu (2011)
10.1016/j.colsurfb.2011.02.033
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Wean Sin Cheow (2011)
10.1016/j.jconrel.2010.08.010
Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
G. Ling (2010)
10.3109/03639048109055684
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
R. Gurny (1981)
10.1016/j.biomaterials.2009.09.036
Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
Y. Liu (2010)
10.1021/LA060188L
Preparation and encapsulation of highly fluorescent conjugated polymer nanoparticles.
C. Wu (2006)
10.1016/j.addr.2009.04.018
siRNA delivery systems for cancer treatment.
Yu-Kyoung Oh (2009)
10.1073/pnas.1115945108
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles
J. M. Chan (2011)
10.1056/NEJMRA0912273
Current concepts: Nanomedicine
Betty Y. S. Kim (2010)
10.1021/jp805865r
Effect of the polymer nature on the structural organization of lipid/polymer particle assemblies.
Julie Thévenot (2008)
10.1016/j.biomaterials.2009.01.005
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.
Carolina Salvador-Morales (2009)
10.1016/j.ijpharm.2010.05.008
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Y. Liu (2010)
10.1016/S0378-5173(97)00135-X
Liposomes in drug delivery: Progress and limitations
Amarnath Sharma (1997)
10.1080/10611860400011950
Increased Resistance of DNA Lipoplexes to Protein Binding In Vitro by Surface-modification with a Multivalent Hydrophilic Polymer
I. Papanicolaou (2004)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1016/J.BBAMEM.2005.02.001
Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression.
E. Ambegia (2005)
10.1016/j.nano.2012.05.008
Nanoparticle delivery for transdermal HRT.
P. Valenzuela (2012)
10.1002/ADMA.200401057
pH‐Triggered Thermally Responsive Polymer Core–Shell Nanoparticles for Drug Delivery
K. Soppimath (2005)
10.1016/j.ejpb.2013.07.002
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Kunn Hadinoto (2013)
10.1016/j.jconrel.2009.03.010
Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Sylvia K E Messerschmidt (2009)
10.1016/S0167-7799(00)89017-4
Engineering liposomes for drug delivery: progress and problems.
G. Gregoriadis (1995)
10.1021/nl104117p
Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.
Elizabeth M. Enlow (2011)
10.1016/j.ejpb.2004.03.008
PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium
M. Bivas-Benita (2004)
10.1016/j.addr.2012.10.007
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yeonhee Yun (2013)
10.2217/nnm.10.6
ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation.
A. Wang (2010)
10.1007/978-1-4419-9745-6_2
Pulmonary Drug Metabolism, Clearance, and Absorption
Bo Olsson (2011)
10.1021/LA050796L
New insights into self-organization of a model lipid mixture and quantification of its adsorption on spherical polymer particles.
Anne-Lise Troutier (2005)
10.1021/nn901433u
Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing.
P. Valencia (2010)
10.1016/S1359-0286(02)00117-1
Biodegradable nanoparticles for drug delivery and targeting
M. Hans (2002)
10.1021/LA047659T
Physicochemical and interfacial investigation of lipid/polymer particle assemblies.
Anne-Lise Troutier (2005)
10.1016/j.biomaterials.2008.12.013
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
J. M. Chan (2009)
10.1021/ar200253u
Molecular Mechanisms of RNA-Triggered Gene Silencing Machineries
Zhonghan Li (2012)
10.1016/0378-5173(94)90036-1
Supramolecular biovectors (SMBV): a new family of nanoparticulate drug delivery systems. Synthesis and structural characterization
M. Peyrot (1994)
10.1146/annurev-bioeng-071811-150124
The effect of nanoparticle size, shape, and surface chemistry on biological systems.
Alexandre Albanese (2012)
10.1002/anie.201101554
Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery.
J. Shi (2011)
10.1007/s11095-006-0282-x
A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
H. L. Wong (2006)



This paper is referenced by
10.3390/nano10102019
Comprehensive Survey on Nanobiomaterials for Bone Tissue Engineering Applications
P. Kumar (2020)
10.1016/j.colsurfb.2020.111082
Self-assembled drug loaded glycosyl-protein metal nanoconstruct: Detailed synthetic procedure and therapeutic effect in solid tumor treatment.
B. Unnikrishnan (2020)
10.1002/pat.5031
Polymeric nanocarriers in targeted drug delivery systems: A review
Payam Abasian (2020)
10.3390/molecules25194377
Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
Ayeskanta Mohanty (2020)
10.1016/j.jconrel.2020.03.050
Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies.
Chih Kit Chung (2020)
10.3390/biomimetics5030032
Cationic Nanostructures for Vaccines Design
Ana Carolina Carmona-Ribeiro (2020)
10.3390/min10020172
Biocompatible Hydrotalcite Nanohybrids for Medical Functions
Wenji Jin (2020)
10.1016/j.medidd.2020.100040
Nanomaterials as potential transporters of HDAC inhibitors
C. D. Souza (2020)
10.1016/J.JDDST.2020.102102
pH-responsive lipid polymer hybrid nanoparticles (LPHNs) based on poly (β-amino ester) as a promising candidate to resist breast cancers
H. Zhang (2020)
10.1080/17425247.2020.1762563
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Madeleine Sa Tan (2020)
10.1016/j.molstruc.2020.128325
Multicomponent and 1,3-dipolar cycloaddition synthesis of triazole- and isoxazole-acridinedione/xanthenedione heterocyclic hybrids: Cytotoxic effects on human cancer cells
Abdelkader Naouri (2020)
10.1016/j.jddst.2020.101993
Nanodiamonds and their surface modification strategies for drug delivery applications
U. T. Uthappa (2020)
10.1016/j.matdes.2020.108805
Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
Jana Ghitman (2020)
10.1039/d0sm00077a
Lipid-core/polymer-shell hybrid nanoparticles: synthesis and characterization by fluorescence labeling and electrophoresis.
Sophie Bou (2020)
10.1016/j.actbio.2020.08.020
Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice.
Sudeep Sudesh Pukale (2020)
10.1039/d0bm00401d
Nanohybrid carriers: the yin-yang equilibrium between natural and synthetic in biomedicine.
F. Ghorbanizamani (2020)
10.2174/1568009620666200115160805
Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
Kuldeep Rajpoot (2020)
10.3390/molecules25184330
The Efficacy of Cholesterol-Based Carriers in Drug Delivery
Ngonidzashe Ruwizhi (2020)
10.1007/s10904-020-01564-z
Single and Multi-metal Oxide Nanoparticles Induced Cytotoxicity and ROS Generation in Human Breast Cancer (MCF-7) Cells
M. A. Siddiqui (2020)
10.5772/intechopen.90248
The Viscosity Behaviour of PEGylated Locust Bean Gum/Rosin Ester Polymeric Nanoparticles
Selcan Karakuş (2019)
10.1007/s00289-020-03184-6
Morphological, structural and cytotoxic behavior of starch/silver nanocomposites with synthesized silver nanoparticles using Stevia rebaudiana extracts
M. Valera-Zaragoza (2020)
10.1002/adfm.201908476
Material, Immunological, and Practical Perspectives on Eye Drop Formulation
Naomi H. Bennett (2020)
10.3390/nano10040656
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
S. Su (2020)
Preprint Title LIPID NANOPARTICLES FOR THE TRANSPORT OF DRUGS LIKE DOPAMINE THROUGH THE BLOOD–BRAIN BARRIER Authors
E. Ortega (2020)
10.1007/s43152-020-00004-x
Innovative Nanotechnological Formulations to Reach the Hepatic Stellate Cell
K. Poelstra (2020)
10.1016/j.molstruc.2019.127590
Molecular docking and inhibitory effects of a novel cytotoxic agent with bovine liver catalase
S. Shahraki (2020)
10.1063/5.0014519
Interactions at engineered graft–tissue interfaces: A review
Wenzhen Zhu (2020)
10.5772/intechopen.88269
Lipid Polymer Hybrid Nanoparticles: A Novel Approach for Drug Delivery
Nayab Tahir (2019)
10.3390/cells9092034
Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA
C. Siewert (2020)
10.1016/j.jddst.2020.101901
QbD based exploration of resveratrol loaded polymeric micelles based carbomer gel for topical treatment of plaque psoriasis: In vitro, ex vivo and in vivo studies
B. Khurana (2020)
10.1007/s13346-020-00818-0
Nanotechnology-based antiviral therapeutics
Malobika Chakravarty (2020)
Semantic Scholar Logo Some data provided by SemanticScholar